/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Zentalis Pharmaceuticals (ZNTL) generated about n/a in revenue and -$124 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.
Zentalis Pharmaceuticals reported about -$124 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
SourceFinancial statements computed from the 10-Q filed 12 May 2026, covering the period ending 31 Mar 2026, as reported to the SEC. Data last refreshed 13 May 2026. How this is calculated.
Fiscal year ends Dec.